Table 1.
Sl no. | Age (years)/ sex | ALT* 6–48 IU/l | AST 7–45 IU/l | HCV RNA (KIU/ml) | Levels of hepatitis | Levels of fibrosis |
---|---|---|---|---|---|---|
1 | 43/Male | 30 | 27 | >850 | Moderate | Mild |
2 | 48/Male | 73 | 58 | >850 | Moderate | Moderate |
3 | 49/Female | 62 | 44 | 190 | Moderate | Moderate |
4 | 57/Male | 71 | 68 | >850 | Mild | Moderate |
5 | 48/Male | 62 | 30 | 600 | Moderate | Severe |
6 | 44/Male | 187 | 101 | 410 | Moderate | Severe |
7 | 69/Female | 115 | 113 | 810 | Moderate | Severe |
8 | 74/Male | 117 | 115 | 550 | Moderate | Moderate |
9 | 45/Male | 72 | 55 | >850 | Moderate | Moderate |
10 | 61/Male | 50 | 45 | >850 | Severe | Severe |
ALT, alanine aminotransferase, AST, aspirate aminotransferase. The levels of hepatitis and fibrosis in the live biopsy specimens of each patient were graded according to the International Criteria, described by Desmet et al. (11).